Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Jun;23(3):521-5.
doi: 10.3346/jkms.2008.23.3.521.

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs

Affiliations
Case Reports

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs

Joo Ho Lee et al. J Korean Med Sci. 2008 Jun.

Abstract

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, characterized by skin rash, fever, lymph node enlargement, and internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, and phenytoin have been reported to cause the DRESS syndrome. We report a case in a 29-yr-old female patient who had been on celecoxib and anti-tuberculosis drugs for one month to treat knee joint pain and pulmonary tuberculosis. Our patient's clinical manifestations included fever, lymphadenopathy, rash, hypereosinophilia, and visceral involvement (hepatitis and pneumonitis). During the corticosteroid administration for DRESS syndrome, swallowing difficulty with profound muscle weakness had developed. Our patient was diagnosed as DRESS syndrome with eosinophilic polymyositis by a histopathologic study. After complete resolution of all symptoms, patch tests were positive for both celecoxib and ethambutol. Although further investigations might be needed to confirm the causality, celecoxib and ethambutol can be added to the list of drugs as having the possibility of DRESS syndrome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diffuse erythema on the patient's right arm (A) and both legs (B).
Fig. 2
Fig. 2
Histologic examination shows intraepidermal eosinophil infiltration and spongiosis. Perivascular inflammatory cell cuffing is also noted. Hematoxylin and eosin stain (H&E), ×400.
Fig. 3
Fig. 3
On histologic examination, myofibers show atrophy and degenerative changes. Interstitial eosinophilic and lymphocytic infiltration is noted. H&E, ×400.
Fig. 4
Fig. 4
Patch test results to celecoxib and anti-Tb drugs.

References

    1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) Semin Cutan Med Surg. 1996;15:250–257. - PubMed
    1. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis. Arch Dermatol. 2001;137:357–364. - PubMed
    1. Marques S, Milpied B, Foulc P, Barbarot S, Cassagnau E, Stalder JF. Severe cutaneous drug reactions to celecoxib (Celebrex) Ann Dermatol Venereol. 2003;130:1051–1055. - PubMed
    1. La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf. 2005;28:917–924. - PubMed
    1. Knowles S, Shapiro L, Shear NH. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of sulfa allergy. Drug Saf. 2001;24:239–247. - PubMed

Publication types

MeSH terms